-
ISIS Pharmaceuticals Cuts License Deal With Bayer AG
Monday, May 4, 2015 - 12:46pm | 190Read More...Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) gained more than 3 percent after the company agreed to license its developmental blood-thinning drug to a unit of Bayer AG (OTC: BAYRY). Carlsbad, California-based Isis changed hands recently at $60.35, up 3.6 percent. Under the license, Isis expects an...
-
Jefferies Raises Zoetis Price Target, Says Consolidation Continues To Look Likely
Wednesday, November 26, 2014 - 10:03am | 207Read More...Jeffrey Holford of Jefferies speculates that consolidation "continues to look likely" for Zoetis Inc (NYSE: ZTS) in 2015. According to Holford, Zoetis' 2015 revenue guidance of $4.85 billion to $4.95 billion and earnings per share of $1.61 to $1.68 were both below expectations but...
-
Market Wrap For Febuary 20: S&P 500 Inches Closer To New Highs
Thursday, February 20, 2014 - 5:46pm | 3262Read More...U.S. stocks overcame mixed economic data and earning reports as the S&P 500 inches towards new all time highs and the Dow recorded an almost triple digit point gain. Jobless claims declined less than expected while consumer prices met expectations and rose slightly. Data from the...
